Ozempic

America’s obesity epidemic is at a crossroads.

A new study shows popular diabetes and obesity drugs can reduce the risk of kidney failure, cardiovascular events, and even death.

The diabetes medication shows promise for improving kidney health and aiding weight loss in patients with chronic kidney disease and obesity.

A new class of drugs, touted by influencers and celebrities, is rising in popularity, however, ‘not all weight loss is healthy.’

Pharmacists have been making copies of weight loss drugs such as Ozempic and Mounjaro, but this is putting patients at risk, according to the TGA.

Plaintiffs claim they suffered from gastroparesis, a condition in which an individual’s stomach fails to properly empty, after taking drugs like Ozempic.

To start 2024, prices hikes on hundreds of drugs are up 22 percent, but record cost savings are expected for Medicaid

The platform offers access to Mounjaro and Zepbound by connecting patients with telehealth professionals for evaluation.

The FDA is also investigating reported side effects of aspiration.

The FDA said it seized numerous units counterfeit weight-loss and diabetes drug Ozempic.

An increasing number of countries are now outlawing the drug for weight loss and are also banning exports.

While Ozempic, Wegovy, and Mounjaro have gained attention for their significant weight loss effects, the drugs’ domestic cost has raised some eyebrows.

Hospitalized people suffered diabetic shock and coma, suggesting the pens contained insulin instead of the ingredient semaglutide.

Criminals have begun selling fake products following a spike in demand and resultant shortage of products.

Dr. Damon Noto discusses the pros and cons of weight loss drugs Ozempic and Mounjaro on VitalSigns.

While Ozempic captures headlines, traditional herbs and spices present compelling alternatives for metabolic health.